Therapy News and Research

RSS

Demonstrating cost and clinical benefits critical to expansion of European seed brachytherapy markets

The nascent European seed brachytherapy market has been grappling with issues of high procedural and investment costs and a lack of local clinical evidence. However, growing evidence of the overall clinical and cost benefits of seed brachytherapy coupled with rising patient awareness is set to boost market expansion.

21 Mar 2005

Chemists say they have identified a gene that appears to play a key role in the development of type 1 diabetes

In the current study, the researchers focused on the formation of the MIF protein (macrophage migration inhibitory factor), a proinflammatory protein that they showed in previous studies is elevated in diabetic animals and may be involved in the cascade of immunological events that leads to the destruction of the pancreas and the subsequent onset of type 1 diabetes.

21 Mar 2005

A new method for analysing the therapy process

In clinical settings, therapy processes are complex dynamical systems where several variables are constantly interacting with each other. In general, the underlying mechanisms are difficult to assess.

21 Mar 2005

Fishing communities are the hidden victims of HIV/AIDS

Men and women living in fishing villages across the world have been found to be between five and ten times more vulnerable to the disease than other communities.

21 Mar 2005

New self-help technology set to combat eating disorders

A new interactive multi-media self-help package for people diagnosed with eating disorders developed by a medical researcher at the University of Glasgow is now set to be delivered over the internet to adolescent sufferers.

21 Mar 2005

Costs of antidepressants could have funded effective alternatives

Some of the costs of prescribing antidepressant drugs over the last decade could have been used to deliver psychological treatments of proven effectiveness, finds a study published online by the BMJ.

21 Mar 2005

NHS Stop-Smoking Services are insufficient to deliver national smoking targets

NHS Stop-Smoking Services are insufficient to deliver national smoking targets, and Government smoking targets are themselves insufficient for the poorest communities, says a study published online by the BMJ.

21 Mar 2005

10% of homosexual men diagnosed late died within a year

1 in 4 HIV-infected homosexual men in England and Wales were diagnosed late in 2001 and 10% died within a year compared to only 0.5% of those not diagnosed late - reports a recent AIDS journal article

17 Mar 2005

UK grows stem cells free of animal products

Dr Paul de Souza and scientists at the Roslin Institute have successfully created human cells without using animal products.

17 Mar 2005

Ongoing specialist care can improve heart attack survival

When a good network of care involving access to specialists and family physicians is established, it can significantly improve the number of lives saved from heart disease, especially in rural areas, according to a University of Alberta two-year study.

16 Mar 2005

Conference to assess evidence on management of menopause-related symptoms

The National Institutes of Health (NIH) will hold a State-of-the-Science Conference on Management of Menopause-Related Symptoms, March 21-23, 2005, at the Natcher Conference Center on the NIH campus in Bethesda, Maryland.

16 Mar 2005

Are sources of affordable generic medicines drying up?

India should ensure global access to medicines when implementing its patent law.

16 Mar 2005

Dental researchers map the gene that causes dentinogenesis imperfecta

Dental researchers at The University of Texas Health Science Center are the first in the world to successfully map the gene that causes dentinogenesis imperfecta (DGI) Type III, a disease that affects tooth density and color and over time can cause teeth to wear to the gum line.

16 Mar 2005

Approval for Temodar (temozolomide) capsules for newly diagnosed glioblastoma multiforme

Schering-Plough today reported that the U.S. Food and Drug Administration (FDA) has granted approval for Temodar (temozolomide) Capsules for use in combination with radiotherapy for the treatment of adult patients with newly diagnosed glioblastoma multiforme (GBM), a form of malignant brain cancer.

16 Mar 2005

Risk of cardiac death after radiation for breast cancer has dramatically decreased

In the largest and most comprehensive prospective study of its kind, researchers at The University of Texas M. D. Anderson Cancer Center have concluded that the risk of ischemic heart disease and, ultimately, cardiac death following radiation treatment for breast cancer has steadily declined over the last quarter century.

16 Mar 2005

Cancer survival comes at its own price

Patients who hear the dreaded words "you have cancer" invariably look forward to the day the doctor tells them "you're cured." But University of Florida researchers say survival often comes at its own price -- the mind may need mending even after the body heals.

16 Mar 2005

Drug combo gives lung cancer patients longer life

Preliminary results from a large randomized clinical trial, sponsored by the National Cancer Institute (NCI), by a network of researchers led by the Eastern Cooperative Oncology Group. Genentech, Inc., have shown that patients with previously untreated advanced non-squamous non-small cell lung cancer who received bevacizumab (Avastin) in combination with standard chemotherapy lived longer than patients who received the same chemotherapy without bevacizumab.

15 Mar 2005

Aspirin use appears to reduce the incidence of colon polyps

The association between regular aspirin use and a reduced risk of precancerous colon polyps may be strongest in those with particular genetic variants.

15 Mar 2005

Antiretroviral therapy may prevent some cancers in people with HIV

In people infected with human immunodeficiency virus (HIV), highly active antiretroviral therapy (HAART) may prevent most excess cases of Kaposi sarcoma and non-Hodgkin lymphoma, according to a new study in the March 16 issue of the Journal of the National Cancer Institute.

15 Mar 2005

Risk of ischemic heart disease associated with radiotherapy for breast cancer has substantially decreased in the last 25 years

The risk of ischemic heart disease that is associated with radiotherapy for breast cancer has substantially decreased in the last 25 years, according to a new study in the March 16 issue of the Journal of the National Cancer Institute.

15 Mar 2005